Results 101 to 110 of about 4,199 (162)

Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. [PDF]

open access: yesNat Rev Neurol
Ziółkowska EA   +5 more
europepmc   +1 more source

Elevated tripeptidyl-peptidase 1 corrects multiple disease phenotypes in a mouse model of juvenile neuronal ceroid lipofuscinosis. [PDF]

open access: yesMol Ther Methods Clin Dev
Banach-Petrosky W   +10 more
europepmc   +1 more source

The yeast phosphofructokinase β-subunit has RNA unwinding activity and modulates cell cycle progression. [PDF]

open access: yesNucleic Acids Res
Albihlal WS   +10 more
europepmc   +1 more source

Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease. [PDF]

open access: yesInt J Mol Sci
Ziółkowska EA   +8 more
europepmc   +1 more source

Impact of CLN3 Disease on Child Quality of Life and Family Function. [PDF]

open access: yesPediatr Neurol
Vermilion J   +6 more
europepmc   +1 more source

Correction: CLN3 disease disrupts very early postnatal hippocampal maturation. [PDF]

open access: yesSci Rep
Singh JB   +8 more
europepmc   +1 more source

Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom. [PDF]

open access: yesOrphanet J Rare Dis
Mole SE   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy